Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Estrogen Receptor alpha | 19 | 2011 | 581 | 2.130 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 14 | 2016 | 165 | 1.750 |
Why?
|
Neoplasms, Hormone-Dependent | 14 | 2011 | 409 | 1.490 |
Why?
|
Receptors, Estrogen | 16 | 2017 | 2252 | 1.480 |
Why?
|
Receptors, Androgen | 15 | 2011 | 1089 | 1.240 |
Why?
|
Estrogens | 10 | 2010 | 1536 | 0.980 |
Why?
|
Response Elements | 5 | 2008 | 308 | 0.790 |
Why?
|
Gene Expression Regulation, Neoplastic | 19 | 2017 | 8628 | 0.760 |
Why?
|
Enhancer Elements, Genetic | 8 | 2011 | 1366 | 0.720 |
Why?
|
Mammary Neoplasms, Experimental | 3 | 2010 | 496 | 0.700 |
Why?
|
Chromatin Immunoprecipitation | 11 | 2009 | 857 | 0.670 |
Why?
|
Estradiol | 12 | 2016 | 1951 | 0.590 |
Why?
|
Breast Neoplasms | 30 | 2022 | 21178 | 0.560 |
Why?
|
Nuclear Receptor Coactivator 3 | 5 | 2010 | 46 | 0.560 |
Why?
|
Transcriptional Activation | 6 | 2009 | 1751 | 0.550 |
Why?
|
Tamoxifen | 6 | 2017 | 966 | 0.540 |
Why?
|
SOX9 Transcription Factor | 1 | 2017 | 145 | 0.530 |
Why?
|
Cell Line, Tumor | 37 | 2017 | 17097 | 0.500 |
Why?
|
Oligonucleotide Array Sequence Analysis | 12 | 2011 | 3797 | 0.500 |
Why?
|
Epidermal Growth Factor | 4 | 2016 | 697 | 0.490 |
Why?
|
RNA, Neoplasm | 2 | 2017 | 748 | 0.480 |
Why?
|
Transcription Factors | 17 | 2011 | 12158 | 0.480 |
Why?
|
Ribonucleoproteins | 1 | 2017 | 358 | 0.470 |
Why?
|
Antineoplastic Agents, Hormonal | 8 | 2017 | 1536 | 0.460 |
Why?
|
Transcription, Genetic | 11 | 2009 | 7611 | 0.450 |
Why?
|
Osteoclasts | 2 | 2008 | 713 | 0.450 |
Why?
|
Promoter Regions, Genetic | 15 | 2010 | 5796 | 0.410 |
Why?
|
RNA Splicing | 1 | 2017 | 903 | 0.410 |
Why?
|
Histone Acetyltransferases | 5 | 2008 | 333 | 0.390 |
Why?
|
Prostatic Neoplasms | 13 | 2017 | 11097 | 0.390 |
Why?
|
DNA Polymerase II | 3 | 2009 | 103 | 0.380 |
Why?
|
E2F1 Transcription Factor | 2 | 2010 | 182 | 0.370 |
Why?
|
Fas Ligand Protein | 2 | 2008 | 216 | 0.350 |
Why?
|
Protein-Arginine N-Methyltransferases | 2 | 2009 | 129 | 0.350 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2017 | 5332 | 0.350 |
Why?
|
Trans-Activators | 5 | 2010 | 2856 | 0.340 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1895 | 0.340 |
Why?
|
Gene Expression Regulation | 10 | 2009 | 11923 | 0.320 |
Why?
|
Cyclin D1 | 2 | 2009 | 453 | 0.300 |
Why?
|
Osteoblasts | 3 | 2008 | 1145 | 0.300 |
Why?
|
Oncogene Proteins | 3 | 2010 | 715 | 0.300 |
Why?
|
Neoplasm Proteins | 3 | 2018 | 3599 | 0.290 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2009 | 632 | 0.280 |
Why?
|
Breast | 3 | 2017 | 1972 | 0.280 |
Why?
|
GATA3 Transcription Factor | 1 | 2007 | 163 | 0.270 |
Why?
|
Androgens | 7 | 2011 | 1281 | 0.260 |
Why?
|
Chromosome Mapping | 4 | 2009 | 4616 | 0.260 |
Why?
|
DNA-Binding Proteins | 9 | 2011 | 9612 | 0.250 |
Why?
|
Histones | 8 | 2011 | 2597 | 0.250 |
Why?
|
Binding Sites | 11 | 2011 | 6014 | 0.250 |
Why?
|
Epigenesis, Genetic | 5 | 2010 | 3828 | 0.240 |
Why?
|
Nuclear Proteins | 5 | 2010 | 5794 | 0.230 |
Why?
|
Estrogen Receptor Modulators | 1 | 2003 | 58 | 0.220 |
Why?
|
Protein Kinases | 2 | 2010 | 1610 | 0.220 |
Why?
|
Chromosomes, Human | 1 | 2005 | 437 | 0.220 |
Why?
|
Models, Biological | 7 | 2010 | 9464 | 0.210 |
Why?
|
Chromatin | 7 | 2017 | 2980 | 0.210 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2010 | 934 | 0.210 |
Why?
|
Oncogenes | 2 | 2006 | 1232 | 0.200 |
Why?
|
Gene Expression Profiling | 13 | 2016 | 9532 | 0.200 |
Why?
|
Genome, Human | 6 | 2010 | 4441 | 0.190 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2002 | 131 | 0.190 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2003 | 221 | 0.190 |
Why?
|
Cell Proliferation | 9 | 2017 | 10455 | 0.190 |
Why?
|
Blotting, Western | 6 | 2011 | 5022 | 0.180 |
Why?
|
Gene Silencing | 6 | 2008 | 1505 | 0.170 |
Why?
|
Diet | 1 | 2018 | 8089 | 0.170 |
Why?
|
Repressor Proteins | 4 | 2008 | 2979 | 0.170 |
Why?
|
Genome-Wide Association Study | 2 | 2017 | 12790 | 0.170 |
Why?
|
Endometrium | 1 | 2002 | 406 | 0.160 |
Why?
|
Tumor Cells, Cultured | 5 | 2009 | 6106 | 0.160 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 4572 | 0.160 |
Why?
|
Osteoporosis | 1 | 2008 | 1604 | 0.150 |
Why?
|
Homeodomain Proteins | 4 | 2011 | 2429 | 0.150 |
Why?
|
Receptors, Progesterone | 4 | 2011 | 1159 | 0.150 |
Why?
|
Protein Binding | 7 | 2009 | 9327 | 0.150 |
Why?
|
Carcinoma | 1 | 2009 | 2326 | 0.140 |
Why?
|
Humans | 71 | 2022 | 767040 | 0.140 |
Why?
|
Bone and Bones | 1 | 2008 | 2587 | 0.140 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2009 | 2887 | 0.140 |
Why?
|
Nucleosomes | 2 | 2011 | 492 | 0.140 |
Why?
|
RNA Polymerase II | 3 | 2007 | 549 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-myc | 3 | 2010 | 998 | 0.130 |
Why?
|
Transfection | 6 | 2009 | 5753 | 0.130 |
Why?
|
Cell Cycle | 4 | 2006 | 2927 | 0.130 |
Why?
|
Genomics | 2 | 2009 | 5924 | 0.130 |
Why?
|
Thyroid Neoplasms | 1 | 2009 | 2355 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2010 | 2457 | 0.130 |
Why?
|
Models, Genetic | 6 | 2011 | 3445 | 0.120 |
Why?
|
Melanoma, Experimental | 1 | 2018 | 557 | 0.120 |
Why?
|
Nuclear Receptor Co-Repressor 1 | 2 | 2005 | 28 | 0.120 |
Why?
|
Conserved Sequence | 2 | 2009 | 1160 | 0.120 |
Why?
|
Adenocarcinoma | 3 | 2011 | 6360 | 0.120 |
Why?
|
Tissue Distribution | 3 | 2008 | 2275 | 0.110 |
Why?
|
Dihydrotestosterone | 4 | 2011 | 195 | 0.110 |
Why?
|
Organ Specificity | 3 | 2010 | 1966 | 0.110 |
Why?
|
Cytokines | 1 | 2008 | 7446 | 0.100 |
Why?
|
Receptor, erbB-2 | 3 | 2022 | 2599 | 0.100 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2002 | 1836 | 0.100 |
Why?
|
Nuclear Receptor Coactivator 2 | 2 | 2002 | 40 | 0.100 |
Why?
|
Acetyltransferases | 2 | 2004 | 230 | 0.100 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2017 | 754 | 0.100 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2002 | 2843 | 0.100 |
Why?
|
Cell Survival | 5 | 2008 | 5750 | 0.100 |
Why?
|
Cell Line | 7 | 2011 | 15567 | 0.100 |
Why?
|
Mice, Transgenic | 4 | 2010 | 9551 | 0.100 |
Why?
|
RNA, Small Interfering | 4 | 2010 | 3427 | 0.100 |
Why?
|
Organic Anion Transporters, Sodium-Independent | 1 | 2011 | 28 | 0.090 |
Why?
|
Genetic Complementation Test | 2 | 2010 | 556 | 0.090 |
Why?
|
Mice | 13 | 2018 | 81912 | 0.090 |
Why?
|
Regulatory Sequences, Nucleic Acid | 3 | 2010 | 792 | 0.090 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2010 | 30 | 0.090 |
Why?
|
Organic Anion Transporters | 1 | 2011 | 101 | 0.090 |
Why?
|
Androgen Antagonists | 3 | 2011 | 1412 | 0.090 |
Why?
|
Mice, Knockout | 4 | 2010 | 14476 | 0.090 |
Why?
|
Signal Transduction | 10 | 2016 | 23621 | 0.080 |
Why?
|
ets-Domain Protein Elk-1 | 1 | 2009 | 39 | 0.080 |
Why?
|
Female | 25 | 2022 | 396660 | 0.080 |
Why?
|
Kruppel-Like Transcription Factors | 2 | 2010 | 506 | 0.080 |
Why?
|
Procollagen-Proline Dioxygenase | 1 | 2009 | 81 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2011 | 1168 | 0.080 |
Why?
|
Membrane Proteins | 2 | 2006 | 7868 | 0.080 |
Why?
|
Orchiectomy | 1 | 2011 | 466 | 0.080 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2011 | 206 | 0.080 |
Why?
|
Carrier Proteins | 1 | 2002 | 4925 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 478 | 0.080 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 482 | 0.080 |
Why?
|
Methylation | 2 | 2009 | 1076 | 0.080 |
Why?
|
PAX2 Transcription Factor | 1 | 2008 | 86 | 0.080 |
Why?
|
Integrin alpha6 | 1 | 2008 | 30 | 0.080 |
Why?
|
Cell Division | 2 | 2009 | 4473 | 0.080 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2009 | 197 | 0.080 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2010 | 451 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 317 | 0.080 |
Why?
|
Tacrolimus Binding Proteins | 2 | 2010 | 199 | 0.080 |
Why?
|
Histone Demethylases | 1 | 2011 | 328 | 0.080 |
Why?
|
Genes, erbB-2 | 1 | 2008 | 162 | 0.070 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2009 | 192 | 0.070 |
Why?
|
Epigenomics | 2 | 2011 | 959 | 0.070 |
Why?
|
Progestins | 1 | 2010 | 302 | 0.070 |
Why?
|
Ovariectomy | 1 | 2010 | 612 | 0.070 |
Why?
|
Animals | 14 | 2018 | 168965 | 0.070 |
Why?
|
Flow Cytometry | 2 | 2009 | 5891 | 0.070 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2010 | 326 | 0.070 |
Why?
|
Glucuronosyltransferase | 1 | 2008 | 136 | 0.070 |
Why?
|
Luciferases | 2 | 2009 | 713 | 0.070 |
Why?
|
Tissue Array Analysis | 1 | 2009 | 545 | 0.070 |
Why?
|
Cell Differentiation | 4 | 2011 | 11657 | 0.070 |
Why?
|
Estrogen Receptor beta | 1 | 2008 | 171 | 0.070 |
Why?
|
Lipids | 1 | 2018 | 3322 | 0.070 |
Why?
|
Proteins | 1 | 2002 | 6001 | 0.070 |
Why?
|
Insulin | 1 | 2002 | 6602 | 0.070 |
Why?
|
Gonadotropin-Releasing Hormone | 2 | 2011 | 1149 | 0.070 |
Why?
|
Histone Code | 1 | 2008 | 160 | 0.070 |
Why?
|
Software | 3 | 2011 | 4472 | 0.070 |
Why?
|
NFI Transcription Factors | 1 | 2006 | 49 | 0.070 |
Why?
|
Immunohistochemistry | 3 | 2011 | 11063 | 0.070 |
Why?
|
3T3 Cells | 1 | 2008 | 1081 | 0.070 |
Why?
|
RNA, Messenger | 6 | 2010 | 12793 | 0.070 |
Why?
|
Transcription Initiation Site | 1 | 2006 | 190 | 0.060 |
Why?
|
Genome | 3 | 2010 | 1752 | 0.060 |
Why?
|
Immunoblotting | 2 | 2009 | 1647 | 0.060 |
Why?
|
Cell Movement | 4 | 2010 | 5203 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2006 | 2902 | 0.060 |
Why?
|
Neoplasms, Basal Cell | 1 | 2006 | 30 | 0.060 |
Why?
|
beta Catenin | 1 | 2011 | 1048 | 0.060 |
Why?
|
Down-Regulation | 3 | 2009 | 2931 | 0.060 |
Why?
|
Ligands | 2 | 2003 | 3273 | 0.060 |
Why?
|
Endometrial Hyperplasia | 1 | 2006 | 102 | 0.060 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2004 | 1939 | 0.060 |
Why?
|
G1 Phase | 1 | 2006 | 403 | 0.060 |
Why?
|
Alkaline Phosphatase | 1 | 2008 | 861 | 0.060 |
Why?
|
Nuclear Receptor Co-Repressor 2 | 1 | 2005 | 33 | 0.060 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2005 | 228 | 0.060 |
Why?
|
Oligonucleotides | 1 | 2008 | 561 | 0.060 |
Why?
|
Gene Dosage | 1 | 2009 | 1211 | 0.060 |
Why?
|
Epithelial Cells | 3 | 2010 | 3698 | 0.060 |
Why?
|
Receptors, CXCR4 | 1 | 2009 | 729 | 0.060 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2005 | 348 | 0.060 |
Why?
|
beta-Naphthoflavone | 1 | 2003 | 5 | 0.060 |
Why?
|
Neurons | 2 | 2011 | 9517 | 0.060 |
Why?
|
Enzyme Activation | 1 | 2010 | 3587 | 0.060 |
Why?
|
Estrogen Antagonists | 1 | 2004 | 151 | 0.060 |
Why?
|
beta-Galactosidase | 1 | 2005 | 573 | 0.060 |
Why?
|
Coculture Techniques | 1 | 2008 | 1337 | 0.060 |
Why?
|
Chromosomes, Human, X | 1 | 2006 | 319 | 0.060 |
Why?
|
Molecular Sequence Data | 5 | 2010 | 17608 | 0.060 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2003 | 88 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2006 | 10748 | 0.050 |
Why?
|
RNA Interference | 3 | 2009 | 2829 | 0.050 |
Why?
|
Microarray Analysis | 1 | 2006 | 751 | 0.050 |
Why?
|
MicroRNAs | 2 | 2009 | 3792 | 0.050 |
Why?
|
DNA, Neoplasm | 1 | 2008 | 1741 | 0.050 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2009 | 2509 | 0.050 |
Why?
|
Mammary Glands, Animal | 1 | 2004 | 273 | 0.050 |
Why?
|
Algorithms | 3 | 2008 | 14098 | 0.050 |
Why?
|
Male | 17 | 2017 | 364203 | 0.050 |
Why?
|
Liver | 1 | 2018 | 7578 | 0.050 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2004 | 414 | 0.050 |
Why?
|
Apoptosis | 2 | 2009 | 9513 | 0.050 |
Why?
|
Nuclear Receptor Coactivator 1 | 1 | 2002 | 42 | 0.050 |
Why?
|
Immunotherapy | 1 | 2018 | 4745 | 0.050 |
Why?
|
Gene Expression | 4 | 2009 | 7587 | 0.050 |
Why?
|
Mice, Inbred C57BL | 3 | 2011 | 22361 | 0.050 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2005 | 422 | 0.050 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2002 | 62 | 0.050 |
Why?
|
Intestines | 1 | 2010 | 1905 | 0.050 |
Why?
|
Aromatase | 1 | 2002 | 147 | 0.050 |
Why?
|
Colonic Neoplasms | 2 | 2010 | 2535 | 0.050 |
Why?
|
Microfilament Proteins | 1 | 2006 | 1130 | 0.050 |
Why?
|
Genes, myc | 1 | 2002 | 391 | 0.040 |
Why?
|
Gene Regulatory Networks | 1 | 2009 | 1752 | 0.040 |
Why?
|
Endopeptidases | 1 | 2004 | 762 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2022 | 9108 | 0.040 |
Why?
|
Cell Line, Transformed | 1 | 2002 | 861 | 0.040 |
Why?
|
Cloning, Molecular | 1 | 2006 | 4167 | 0.040 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2008 | 1608 | 0.040 |
Why?
|
Caco-2 Cells | 2 | 2010 | 364 | 0.040 |
Why?
|
Precancerous Conditions | 1 | 2006 | 980 | 0.040 |
Why?
|
Cell Lineage | 1 | 2009 | 2575 | 0.040 |
Why?
|
Sirolimus | 1 | 2006 | 1539 | 0.040 |
Why?
|
Macromolecular Substances | 1 | 2002 | 1430 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2010 | 3610 | 0.040 |
Why?
|
NF-kappa B | 1 | 2008 | 2493 | 0.040 |
Why?
|
Chromosome Aberrations | 1 | 2006 | 1776 | 0.040 |
Why?
|
Intestinal Mucosa | 1 | 2010 | 3043 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2022 | 13650 | 0.040 |
Why?
|
Mice, Inbred BALB C | 1 | 2008 | 6226 | 0.040 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2008 | 1076 | 0.040 |
Why?
|
Base Sequence | 4 | 2010 | 12414 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2022 | 705 | 0.040 |
Why?
|
Cell Growth Processes | 2 | 2009 | 380 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2022 | 562 | 0.040 |
Why?
|
In Situ Hybridization | 1 | 2002 | 1892 | 0.040 |
Why?
|
DNA | 2 | 2008 | 7210 | 0.040 |
Why?
|
Homeostasis | 1 | 2009 | 3345 | 0.040 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2006 | 2061 | 0.040 |
Why?
|
Histone Deacetylases | 1 | 2002 | 712 | 0.040 |
Why?
|
Antigens, CD | 1 | 2008 | 4032 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 1 | 2002 | 1058 | 0.040 |
Why?
|
Prostate | 1 | 2005 | 1761 | 0.030 |
Why?
|
Dioxygenases | 2 | 2009 | 353 | 0.030 |
Why?
|
Serpins | 1 | 2018 | 246 | 0.030 |
Why?
|
Telomerase | 1 | 2002 | 751 | 0.030 |
Why?
|
Transcription Factor AP-2 | 1 | 2016 | 78 | 0.030 |
Why?
|
Enzyme Inhibitors | 2 | 2003 | 3726 | 0.030 |
Why?
|
Obesity | 1 | 2018 | 13085 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2005 | 2463 | 0.030 |
Why?
|
Indoles | 1 | 2003 | 1836 | 0.030 |
Why?
|
Bone Density | 1 | 2008 | 3573 | 0.030 |
Why?
|
Polymorphism, Genetic | 2 | 2002 | 4247 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2006 | 3561 | 0.030 |
Why?
|
Biological Transport | 2 | 2011 | 2084 | 0.030 |
Why?
|
Protein Isoforms | 2 | 2010 | 1716 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2006 | 4210 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2002 | 3738 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2016 | 6844 | 0.030 |
Why?
|
HeLa Cells | 2 | 2009 | 3073 | 0.030 |
Why?
|
Nitriles | 2 | 2009 | 980 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2002 | 2448 | 0.030 |
Why?
|
Endometrial Neoplasms | 1 | 2002 | 1381 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 1105 | 0.030 |
Why?
|
Cohort Studies | 3 | 2010 | 41718 | 0.020 |
Why?
|
Incidence | 1 | 2010 | 21526 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2002 | 2800 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 16036 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2018 | 1801 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2006 | 18989 | 0.020 |
Why?
|
GATA6 Transcription Factor | 1 | 2010 | 54 | 0.020 |
Why?
|
Cell Adhesion | 2 | 2008 | 3093 | 0.020 |
Why?
|
Promegestone | 1 | 2010 | 9 | 0.020 |
Why?
|
Octamer Transcription Factor-1 | 1 | 2010 | 30 | 0.020 |
Why?
|
Plicamycin | 1 | 2010 | 12 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2002 | 13411 | 0.020 |
Why?
|
Hepatocyte Nuclear Factor 4 | 1 | 2010 | 127 | 0.020 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2011 | 241 | 0.020 |
Why?
|
GA-Binding Protein Transcription Factor | 1 | 2009 | 43 | 0.020 |
Why?
|
Angiomyolipoma | 1 | 2011 | 189 | 0.020 |
Why?
|
Serum Response Factor | 1 | 2009 | 78 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2002 | 4522 | 0.020 |
Why?
|
Cell Nucleus | 2 | 2010 | 2875 | 0.020 |
Why?
|
Neoplasm Metastasis | 2 | 2010 | 4892 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 474 | 0.020 |
Why?
|
Tosyl Compounds | 1 | 2009 | 115 | 0.020 |
Why?
|
E2F Transcription Factors | 1 | 2009 | 270 | 0.020 |
Why?
|
Oxidoreductases, N-Demethylating | 1 | 2009 | 109 | 0.020 |
Why?
|
Arabidopsis Proteins | 1 | 2010 | 261 | 0.020 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2009 | 183 | 0.020 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2010 | 501 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2009 | 740 | 0.020 |
Why?
|
Melanocytes | 1 | 2011 | 509 | 0.020 |
Why?
|
Propionates | 1 | 2008 | 180 | 0.020 |
Why?
|
Phosphorylcholine | 1 | 2008 | 152 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2011 | 59548 | 0.020 |
Why?
|
Androgen Receptor Antagonists | 1 | 2008 | 123 | 0.020 |
Why?
|
Ribonuclease III | 1 | 2009 | 271 | 0.020 |
Why?
|
Chemokine CXCL12 | 1 | 2009 | 457 | 0.020 |
Why?
|
Postmenopause | 1 | 2016 | 2518 | 0.020 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2008 | 303 | 0.020 |
Why?
|
Mammary Glands, Human | 1 | 2008 | 201 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2011 | 13491 | 0.020 |
Why?
|
Anoikis | 1 | 2006 | 49 | 0.020 |
Why?
|
Retinoblastoma Protein | 1 | 2010 | 670 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2010 | 723 | 0.020 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2010 | 857 | 0.020 |
Why?
|
Uniparental Disomy | 1 | 2006 | 46 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2010 | 1604 | 0.020 |
Why?
|
Isoenzymes | 1 | 2010 | 1688 | 0.020 |
Why?
|
Anilides | 1 | 2009 | 413 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2010 | 1526 | 0.020 |
Why?
|
Genes, X-Linked | 1 | 2006 | 129 | 0.020 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2006 | 286 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2018 | 3944 | 0.020 |
Why?
|
Sweden | 1 | 2008 | 1382 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2010 | 1244 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2008 | 1989 | 0.010 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2011 | 1493 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2018 | 4648 | 0.010 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2006 | 418 | 0.010 |
Why?
|
Molecular Chaperones | 1 | 2009 | 760 | 0.010 |
Why?
|
Phenols | 1 | 2008 | 526 | 0.010 |
Why?
|
DNA Methylation | 2 | 2011 | 4426 | 0.010 |
Why?
|
Area Under Curve | 1 | 2008 | 1639 | 0.010 |
Why?
|
Boronic Acids | 1 | 2008 | 915 | 0.010 |
Why?
|
Drug Synergism | 1 | 2008 | 1759 | 0.010 |
Why?
|
Phenotype | 1 | 2002 | 16718 | 0.010 |
Why?
|
MAP Kinase Signaling System | 1 | 2010 | 1492 | 0.010 |
Why?
|
Middle Aged | 4 | 2016 | 223233 | 0.010 |
Why?
|
Gene Deletion | 1 | 2011 | 2668 | 0.010 |
Why?
|
Time Factors | 1 | 2005 | 40154 | 0.010 |
Why?
|
Tuberous Sclerosis | 1 | 2011 | 1039 | 0.010 |
Why?
|
Serine Endopeptidases | 1 | 2008 | 1027 | 0.010 |
Why?
|
Alleles | 2 | 2006 | 6893 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4114 | 0.010 |
Why?
|
Genotype | 2 | 2011 | 13035 | 0.010 |
Why?
|
Disease Progression | 2 | 2011 | 13646 | 0.010 |
Why?
|
Pregnancy | 1 | 2004 | 30238 | 0.010 |
Why?
|
RNA, Untranslated | 1 | 2006 | 455 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2009 | 1646 | 0.010 |
Why?
|
Pyrazines | 1 | 2008 | 1204 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2009 | 1312 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2016 | 12451 | 0.010 |
Why?
|
Mice, Nude | 1 | 2008 | 3618 | 0.010 |
Why?
|
Keratinocytes | 1 | 2006 | 876 | 0.010 |
Why?
|
Up-Regulation | 1 | 2010 | 4143 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2018 | 9245 | 0.010 |
Why?
|
CpG Islands | 1 | 2006 | 1206 | 0.010 |
Why?
|
Genetic Loci | 1 | 2010 | 2629 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6513 | 0.010 |
Why?
|
Testosterone | 1 | 2011 | 2490 | 0.010 |
Why?
|
Phosphorylation | 1 | 2011 | 8310 | 0.010 |
Why?
|
Aged | 2 | 2011 | 171319 | 0.010 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2002 | 781 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2008 | 3611 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2008 | 2391 | 0.010 |
Why?
|
Adult | 3 | 2011 | 223317 | 0.010 |
Why?
|
BRCA1 Protein | 1 | 2006 | 1155 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18330 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6067 | 0.010 |
Why?
|
Health Surveys | 1 | 2008 | 4056 | 0.010 |
Why?
|
Pyrazoles | 1 | 2008 | 2028 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2009 | 3440 | 0.010 |
Why?
|
Hormone Replacement Therapy | 1 | 2002 | 756 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2003 | 65295 | 0.010 |
Why?
|
Brachytherapy | 1 | 2002 | 1220 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2002 | 2900 | 0.010 |
Why?
|
Prostatectomy | 1 | 2002 | 1786 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2002 | 4855 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2011 | 4282 | 0.010 |
Why?
|
Internet | 1 | 2006 | 3114 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2002 | 22254 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2002 | 2428 | 0.010 |
Why?
|
Regression Analysis | 1 | 2002 | 6331 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2009 | 9410 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2002 | 8535 | 0.010 |
Why?
|
Physicians | 1 | 2008 | 4593 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 8048 | 0.010 |
Why?
|
Risk Factors | 2 | 2010 | 74886 | 0.010 |
Why?
|
Prognosis | 1 | 2010 | 29963 | 0.000 |
Why?
|
Neoplasm Staging | 1 | 2002 | 11217 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 11872 | 0.000 |
Why?
|
Quality of Life | 1 | 2002 | 13485 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2002 | 18063 | 0.000 |
Why?
|
Prospective Studies | 1 | 2002 | 54886 | 0.000 |
Why?
|